How Frontotemporal Dementia Affects Vision and Eyes

Frontotemporal dementia affects vision and the eyes in ways that are both broader and more surprising than most people expect. Unlike conditions that blur or dim what the eyes physically take in, FTD primarily disrupts how the brain processes, directs, and interprets visual information. That means a person with FTD can pass a standard eye chart test yet struggle to copy a simple drawing, recognize a spouse’s face, or shift their gaze on command. Research over the past decade has also revealed physical changes in the retina and the tiny nerves of the eye itself, suggesting the disease reaches further than the brain alone.

Visuospatial Processing Breaks Down Differently Than in Alzheimer’s

People often associate visual-spatial problems with Alzheimer’s disease, and rightly so. But behavioral variant FTD (bvFTD), the most common form of frontotemporal dementia, brings its own distinct pattern of visuospatial trouble. When researchers compared bvFTD and Alzheimer’s patients on tasks like copying geometric figures, both groups performed worse than healthy adults, but the reasons differed. In Alzheimer’s, poor figure copying was linked to problems with basic spatial perception and attention. In bvFTD, the breakdown was tied to higher-level spatial planning and working memory. Even after accounting for perception and attention, planning deficits still explained a unique share of bvFTD patients’ drawing difficulties.

1PubMed Central. Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer’s disease and behavioral variant frontotemporal dementia

On most formal visuospatial tests, Alzheimer’s patients actually scored worse than bvFTD patients, particularly on drawing tasks and spatial orientation. But this does not mean bvFTD spares visuospatial ability altogether. When researchers tested orientation in personal space versus map-based navigation, bvFTD and Alzheimer’s patients faltered at different stages: Alzheimer’s patients had more trouble judging their own heading direction, while bvFTD patients showed a different mix of impairments depending on task demands.

2PubMed. Visuospatial dysfunction in Alzheimer’s disease and behavioural variant frontotemporal dementia3PubMed. Egocentric versus Allocentric Spatial Memory in Behavioral Variant Frontotemporal Dementia and Alzheimer’s Disease

The practical upshot is that a person with bvFTD may be able to see a room perfectly well but struggle to mentally organize what they see, to plan a sequence of actions based on visual input, or to hold a spatial layout in mind while doing something else. This “top-down” failure in visual processing is easy to miss on casual observation because the eyes look fine and the person can describe objects in front of them.

Eye Movement Problems in Behavioral Variant FTD

Your eyes do not simply stare at the world passively. Rapid, darting eye movements called saccades redirect your gaze dozens of times per minute, and the brain exercises tight control over when and where those movements go. In bvFTD, the most telling eye movement problem involves anti-saccades, a lab test in which a person must look away from a suddenly appearing target rather than toward it. This requires inhibiting the automatic urge to glance at something new, and bvFTD patients perform significantly worse on this task, a deficit that tracks closely with their broader executive function problems.

4PubMed Central. Eye movements in frontotemporal dementia: Abnormalities of fixation, saccades and anti-saccades

Visual search behavior tells a related story. When bvFTD patients scan a visual scene looking for a target, they are less accurate, slower, and make more eye movements that cover greater distances than healthy adults. They are not simply cautious or inattentive; the entire search strategy is less efficient, as if the internal map that guides “where to look next” has degraded.

5Journal of Alzheimer’s Disease. Visual Search in Behavioral Variant Frontotemporal Dementia

These eye movement disruptions are subtle enough that a family member might never notice them directly. What they often notice instead are downstream effects: the person seems to overlook things in plain sight, loses track of objects while reaching for them, or appears “zoned out” when the real problem is that their gaze is not landing where it needs to.

When the FTD Spectrum Attacks Eye Movement More Directly

FTD is not a single disease but a family of related conditions. Two disorders within that spectrum, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), produce eye movement problems that are far more obvious and physically disabling than what bvFTD alone causes.

PSP is perhaps best known for its effect on vertical gaze. All clinical subtypes of PSP show significantly slower vertical saccades and smooth pursuit compared to patients with Parkinson’s disease, and this difficulty looking up and down is often one of the earliest signs a clinician recognizes.

6PubMed. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy

CBD attacks eye control differently. Rather than slowing the eyes uniformly, it tends to delay the initiation of saccades on the side of the body showing the most motor symptoms, impair smooth tracking movements, and produce oculomotor apraxia, a condition in which a person cannot voluntarily direct their gaze to a target even though the eyes are physically capable of moving. One case report described a 60-year-old woman whose progressive visual complaints turned out to stem primarily from severe oculomotor apraxia combined with an inability to process more than one visual object at a time, a symptom known as simultanagnosia.

7PubMed. Visual signs and symptoms of corticobasal degeneration8Journal of Neuro-Ophthalmology. Visual Involvement in Corticobasal Syndrome

For caregivers, this distinction matters. A person with PSP who struggles to look down at their plate or at stairs is dealing with a fundamentally different visual impairment than someone with bvFTD who can physically move their eyes but can’t strategically direct visual attention. Both need environmental modifications, but the modifications themselves differ.

Losing the Ability to Recognize Faces and Objects

One of the more distressing visual symptoms in FTD has nothing to do with acuity or eye movement. In the right temporal variant of FTD, atrophy concentrated in the right side of the brain’s temporal pole can erode the ability to recognize familiar faces, a condition called prosopagnosia. In a large multicenter study of patients with right-predominant anterior temporal atrophy, about 60% had face-recognition deficits. These patients could see a face clearly, describe its features, and even note that the person seemed familiar, yet could not connect the face to an identity.

9PubMed Central. Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study

In some cases this extends beyond faces to objects. One well-documented patient, a 54-year-old woman, first noticed difficulty recognizing people at work, then gradually lost the ability to identify familiar objects by sight, a pattern researchers describe as associative visual object agnosia. Her MRI showed the expected right temporal pole atrophy extending into nearby visual processing areas. The problem was not with her eyes or even with basic visual perception; it was a disconnection between what she saw and what the image meant.

10Brain. Temporopolar regions of the human brain

This type of impairment is easily mistaken for memory loss or inattention. A family might assume a loved one “forgot” a neighbor’s face or “wasn’t paying attention” at a gathering, when the real issue is that the brain’s visual recognition system has been selectively dismantled by disease.

How FTD Changes the Way People Look at Faces

Even when face recognition is still intact, FTD alters how the eyes engage with other people’s faces. In healthy conversation, your gaze naturally drifts between another person’s eyes, mouth, and broader facial expression. Researchers using eye-tracking technology found that bvFTD patients spent significantly less time looking at the mouth area of faces compared to both healthy controls and people with psychiatric disorders that can mimic bvFTD’s behavioral symptoms. Interestingly, time spent gazing at the eye region did not differ between groups.

11European Journal of Neurology. Decreased emotion recognition and reduced focus on facial hallmarks in behavioral variant frontotemporal dementia compared to primary psychiatric disorders and controls

The mouth carries a large share of emotional and social information, especially for nuanced expressions like a sarcastic smile or a nervous grin. Spending less time fixating on the mouth may contribute to the well-known difficulty bvFTD patients have in reading others’ emotions, a problem that family members often describe as the person becoming “cold” or “indifferent.” It is not always that they lack empathy in the emotional sense. Sometimes they literally are not gathering the visual data that most of us use to decode another person’s feelings.

Visual Hallucinations in FTD

Visual hallucinations are not the hallmark of FTD the way they are in Lewy body dementia, but they do occur in a meaningful subset of patients. When researchers compared FTD patients who experienced hallucinations with those who did not, brain imaging revealed that the hallucinating group had significantly reduced grey matter in a wide network of regions. These included frontal areas involved in attention and executive control, the occipital cortex where basic visual processing happens, and the striatum, a structure deep in the brain involved in filtering sensory information.

12Brain Communications. An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia

The researchers proposed that hallucinations in FTD arise when both attentional control and working memory degrade to the point that the brain can no longer distinguish internally generated images from real sensory input. This fits with what clinicians observe: hallucinations tend to appear in patients who already have pronounced cognitive decline, rather than as an early symptom. For caregivers, understanding that hallucinations stem from a measurable loss of brain tissue, rather than “imagination” or psychological disturbance, can be both reassuring and useful in guiding conversations with medical providers.

Physical Changes in the Retina and Cornea

Until recently, FTD was considered a disease of the brain with no direct impact on the eye’s physical structures. That picture has changed. Using optical coherence tomography (OCT), a non-invasive scan that measures the thickness of retinal layers, researchers found that the retinal nerve fiber layer (RNFL) is significantly thinner in FTD patients than in healthy controls. In one study, the difference was more pronounced in FTD than even in mild Alzheimer’s disease.

13PubMed. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer’s Disease

The blood supply to the retina also appears affected. A study using OCT angiography, which maps tiny blood vessels without dye injection, showed that blood flow density in both the optic nerve head and in the superficial and deep capillary layers of the macula was significantly reduced in FTD patients compared to controls.

14PubMed Central. Quantitative Analysis of Retinal Perfusion in Patients with Frontotemporal Dementia Using Optical Coherence Tomography Angiography

Perhaps most striking, post-mortem analysis of retinal tissue from people who carried the two most common genetic mutations behind familial FTD (C9orf72 repeat expansions and GRN mutations) found phosphorylated TDP-43 inclusions, the same toxic protein deposits found in the brain, inside the inner retinal layers. Every mutation carrier examined had these inclusions; none of the control subjects did. The retinas also showed increased activation of the brain’s immune-like cells and signs of reactive inflammation.

15PubMed Central. TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Even the cornea, the transparent front surface of the eye, shows measurable damage. Corneal confocal microscopy has revealed progressive reductions in nerve fiber density, branch density, and fiber length in people with dementia compared to healthy adults. These corneal nerve measures correlated with cognitive function and daily independence, and could distinguish dementia from normal aging with reasonable accuracy.

16PubMed Central. Association of corneal nerve fiber measures with cognitive function in dementia

None of these retinal or corneal findings are specific enough to diagnose FTD on their own. But they raise the possibility that a quick, painless eye scan could one day serve as an early screening tool, or at least help track disease progression without the expense and limited availability of brain imaging.

Reading Difficulties in Primary Progressive Aphasia

Primary progressive aphasia (PPA), a language-dominant form of FTD, creates a different kind of visual problem: reading falls apart not because the eyes can’t track text but because the brain can’t connect written words to their meanings. In the semantic variant of PPA (PPA-S), where word comprehension gradually erodes, eye-tracking studies reveal a telling pattern. When shown a spoken word and asked to look at the matching picture among several options, PPA-S patients gazed almost equally at the correct picture and at closely related distractors, even on trials where they ultimately chose the right answer. By contrast, patients with the nonfluent variant (PPA-NF), whose comprehension is relatively preserved, showed a clear gaze preference for the target.

17PubMed Central. Eye Movements as a Measure of Word Comprehension Deficits in Primary Progressive Aphasia

What makes this finding useful is that the eye-tracking pattern revealed the degree of semantic loss more sensitively than a simple right-or-wrong accuracy score. A person with PPA-S might still pick the correct picture, but their eyes betray the underlying confusion. For clinicians, this means gaze patterns could help detect deterioration before the patient starts getting answers outright wrong on conventional tests.

Pupillary Responses as a Window into Cognitive Effort

Your pupils dilate slightly when you concentrate on a demanding mental task. Researchers have used this principle to compare how much cognitive effort different tasks cost bvFTD patients, Alzheimer’s patients, and healthy controls. All three groups showed wider pupils during a mental subtraction task than during simple counting, confirming that the basic pupillary effort response still works. However, bvFTD patients had consistently smaller resting pupil diameters than Alzheimer’s patients, who in turn had smaller pupils than controls.

18Alzheimer Disease & Associated Disorders. Pupillometry as a Differential Indicator of Cognitive Processing in Alzheimer Disease and Behavioral Variant Frontotemporal Dementia

This smaller baseline pupil size in bvFTD may reflect changes in the autonomic nervous system, which controls involuntary functions including pupil dilation. It is a subtle finding with no direct impact on daily vision, but it adds to the growing picture of FTD as a disease that leaves fingerprints throughout the body’s neural wiring, not just in the brain regions responsible for behavior and language.

Driving Safety and Real-World Hazard Perception

One of the most consequential ways FTD’s visual and cognitive effects collide is behind the wheel. Researchers examining driving errors across different dementia types hypothesized that Alzheimer’s patients are more likely to make strategic errors, like getting lost on a familiar route, while FTD patients are more prone to tactical errors, like failing to notice and react to hazards in real time. This tracks with the attention and visual-search deficits described in bvFTD: the person’s route memory may be relatively intact, but the rapid visual scanning, impulse control, and hazard assessment needed for safe driving are precisely the skills that degrade early.

19Taylor & Francis Online (Traffic Injury Prevention). Car drivers with dementia: Different complications due to different etiologies?

This makes driving cessation conversations with FTD patients especially fraught. The person may insist they “know where they’re going” and feel offended at the suggestion they can’t drive, because their spatial navigation might still be fine. The danger lies in what they miss at intersections, in blind spots, or in fast-moving traffic, problems that are nearly invisible until a near-miss or an accident makes them undeniable.

Emergent Visual Creativity

Not everything FTD does to visual processing is loss. A small but well-documented minority of FTD patients develop new or intensified interest in visual art, sometimes producing strikingly original work despite having no previous artistic inclination. Early case reports noted that patients with the temporal lobe variant of FTD sometimes showed facilitation of artistic skills as language and social cognition declined.

20PubMed. Emergence of artistic talent in frontotemporal dementia

More recent imaging work has offered a possible explanation. The pattern of brain atrophy in FTD appears to be inversely correlated with activity in the dorsal occipital cortex, a region involved in visual-spatial processing and visual imagery. In other words, as the front and sides of the brain lose tissue, the back of the brain, where visual processing is centered, may become functionally disinhibited. Researchers have proposed that this network rebalancing pushes some patients toward visual creativity, though it likely only manifests as art when conditions such as latent talent or an encouraging environment are already present.

21JAMA Neurology. Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia

For families, this phenomenon can be bittersweet. A loved one who never painted may begin producing vivid, compulsive visual art at the same time they are losing the ability to hold a conversation or recognize a friend. The creativity is real, not a quirk of the diagnosis, and some clinicians have begun incorporating art-based activities into care plans, not as therapy for the disease itself but as a way to maintain engagement and quality of life while other capacities fade.

Ellen Callahan

Ellen Callahan, MD, PhD, is a behavioral neurologist and clinical researcher at an academic memory and aging center. She writes about cognitive disorders and dementia. Over 23 years in clinical neurology, she has evaluated patients with memory impairment and directed clinical trials tracking neurodegenerative conditions. Her laboratory research examines spinal fluid biomarkers to identify protein changes during the earliest stages of Alzheimer's disease. Callahan received an undergraduate degree in cognitive science from Fordham University and completed a doctorate in neuroscience at Weill Cornell Medicine.